1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 03/2007, NCT00719017
|
|
2.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GUM-ET/OV, NCT01389986
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000521447; P06.031, CKTO-2006-04, ISRCTN14387080, P06.031-PORTEC-3, 2007-004917-33, CKTO-PORTEC-3, EU-20664, NCT00411138
|
|
4.
|
Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
|
|
5.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: SARC-GYN1, NCT00162721
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 2 to 21 Sponsor: NCI Protocol IDs: SCUSF-0703, MCC-0703, SCUSF 0703, NCT01132547
|
|
7.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 0014-08-RMC, NCT00726635
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0249, GOG-0249, NCT00807768
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TOTEM, NCT00916708
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and older Sponsor: NCI Protocol IDs: GOG-0258, GOG-0258, NCT00942357
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039
|
|
13.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 200917341, CFEM 345AUS63, NCT00997373
|
|
14.
|
Phase: Phase III Type: Health services research, Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268
|
|
15.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: ENGOT-EN2-DGCG/EORTC55102, 2010-023081-52, NCT01244789
|
|
16.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RC08/118, NCT01356329
|
|
17.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N10C1, N10C1, NCT01376349
|
|
18.
|
Phase: Phase III Type: Supportive care Status: Active Age: 20 to 70 Sponsor: Other Protocol IDs: IV iron 2, NCT01435200
|
|
19.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: TACH-01, NCT01470677
|
|
20.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 16 and over Sponsor: Other Protocol IDs: PPS-MERT-01, NCT01509313
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: TOMOGYN - 1105, NCT01641497
|
|
22.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
|
|
23.
|
Phase: Phase III Type: Behavioral study, Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 50 to 60 Sponsor: Other Protocol IDs: 2011-0739, NCT01697566
|
|
24.
|
Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00600, U10CA080098, CDR0000521453, GOG-0233, ACRIN-6671, NCT00416455
|
|
25.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
|